Core Viewpoint - Dalian Thermal Power's stock has experienced a decline of 8.84% year-to-date, with a recent drop of 2.11% on November 18, 2023, indicating potential challenges in the company's market performance [1]. Financial Performance - For the period from January to September 2025, Dalian Thermal Power reported operating revenue of 380 million yuan, a year-on-year decrease of 6.32%. The net profit attributable to shareholders was -113 million yuan, reflecting a year-on-year increase of 3.28% [2]. Shareholder Information - As of November 10, 2023, the number of shareholders for Dalian Thermal Power was 39,000, a decrease of 2.50% from the previous period. The average number of tradable shares per shareholder increased by 2.56% to 10,374 shares [2]. Dividend Distribution - Since its A-share listing, Dalian Thermal Power has distributed a total of 186 million yuan in dividends. However, there have been no dividend distributions in the past three years [3]. Institutional Holdings - As of September 30, 2025, the second-largest circulating shareholder of Dalian Thermal Power is the Nuoan Multi-Strategy Mixed A fund, holding 2.5439 million shares, indicating new institutional interest [3].

Core Viewpoint - Shenyang Machine Tool has shown significant stock performance with a year-to-date increase of 19.13% and a notable rise in revenue and profit for the first nine months of 2025, indicating strong operational growth and market interest [1][2]. Financial Performance - As of September 30, 2025, Shenyang Machine Tool achieved a revenue of 2.544 billion yuan, representing a year-on-year growth of 154.42% [2]. - The net profit attributable to shareholders for the same period was 1.1454 million yuan, reflecting a year-on-year increase of 100.93% [2]. Stock Market Activity - On November 18, the stock price increased by 2.05%, reaching 8.47 yuan per share, with a trading volume of 168 million yuan and a turnover rate of 1.20% [1]. - The total market capitalization of Shenyang Machine Tool is 22.438 billion yuan [1]. Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 0.60% to 75,000, while the average number of circulating shares per person increased by 0.60% to 22,411 shares [2]. - The company has cumulatively distributed 71.902 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Institutional Holdings - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the seventh largest, holding 19.0666 million shares, an increase of 6.3182 million shares compared to the previous period [3]. Business Overview - Shenyang Machine Tool, established on May 20, 1993, and listed on July 18, 1996, specializes in product research and development, machine tool manufacturing, sales services, and industry solutions [1]. - The company's main revenue sources include metal cutting machine tools (57.38%), metal forming machine tools (29.20%), and other products (13.42%) [1]. Industry Classification - Shenyang Machine Tool is classified under the machinery equipment sector, specifically in general equipment and machine tools [1]. - The company is associated with several concept sectors, including Northeast revitalization, debt-to-equity swaps, wind energy, state-owned enterprise reform, and margin financing [1].

Core Viewpoint - Ansteel Co., Ltd. experienced a decline in stock price, with a current trading price of 2.73 CNY per share, reflecting a 2.15% drop on November 18. The company has seen a year-to-date stock price increase of 13.75% but has faced recent declines over the past five and twenty trading days [1]. Financial Performance - For the period from January to September 2025, Ansteel reported a revenue of 73.092 billion CNY, representing a year-on-year decrease of 7.78%. The net profit attributable to shareholders was -2.040 billion CNY, showing a significant year-on-year increase of 59.87% [2]. Shareholder Information - As of September 30, 2025, Ansteel had 95,700 shareholders, a decrease of 0.45% from the previous period. The average circulating shares per shareholder remained at 0 [2]. - The company has distributed a total of 21.437 billion CNY in dividends since its A-share listing, with a cumulative payout of 6.392 million CNY over the past three years [3]. Institutional Holdings - Among the top ten circulating shareholders as of September 30, 2025, Hong Kong Central Clearing Limited held 77.9972 million shares, an increase of 25.3221 million shares from the previous period. The Southern CSI 500 ETF held 34.9382 million shares, a decrease of 0.8428 million shares, while the Guotai CSI Steel ETF entered as a new shareholder with 24.0346 million shares [3].

11月17日，通化金马盘中上涨2.23%，截至11:05，报29.39元/股，成交3.93亿元，换手率1.41%，总市值 284.05亿元。 资金流向方面，主力资金净流出1759.63万元，特大单买入2862.41万元，占比7.28%，卖出4253.98万 元，占比10.82%；大单买入1.15亿元，占比29.36%，卖出1.19亿元，占比30.29%。 通化金马所属申万行业为：医药生物-化学制药-化学制剂。所属概念板块包括：民营医院、工业大麻、 东北振兴、肝炎治疗、中药等。 截至9月30日，通化金马股东户数3.82万，较上期减少3.20%；人均流通股25266股，较上期增加3.31%。 2025年1月-9月，通化金马实现营业收入8.92亿元，同比减少7.88%；归母净利润2496.35万元，同比增长 4.35%。 分红方面，通化金马A股上市后累计派现2.10亿元。近三年，累计派现0.00元。 机构持仓方面，截止2025年9月30日，通化金马十大流通股东中，创新药（159992）位居第七大流通股 东，持股919.30万股，相比上期增加8.78万股。南方中证1000ETF（512100）位居第八大流通股东，持 ...

Core Viewpoint - Shenyang Machine Tool experienced a decline in stock price by 2.00% on November 17, with a current price of 8.31 CNY per share and a total market capitalization of 22.014 billion CNY [1] Financial Performance - For the period from January to September 2025, Shenyang Machine Tool achieved operating revenue of 2.544 billion CNY, representing a year-on-year increase of 154.42% [2] - The net profit attributable to the parent company for the same period was 1.1454 million CNY, showing a year-on-year growth of 100.93% [2] Stock Market Activity - As of November 17, the stock had a trading volume of 209 million CNY and a turnover rate of 1.47% [1] - The stock price has increased by 16.88% year-to-date, with a recent decline of 1.66% over the last five trading days [1] Shareholder Information - As of September 30, 2025, the number of shareholders for Shenyang Machine Tool was 75,000, a decrease of 0.60% from the previous period [2] - The average number of circulating shares per shareholder increased by 0.60% to 22,411 shares [2] Dividend Information - Since its A-share listing, Shenyang Machine Tool has distributed a total of 71.902 million CNY in dividends, with no dividends paid in the last three years [3] Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the seventh largest circulating shareholder, holding 19.0666 million shares, an increase of 6.3182 million shares from the previous period [3] Business Overview - Shenyang Machine Tool, established on May 20, 1993, and listed on July 18, 1996, is primarily engaged in product research and development, machine tool manufacturing, sales services, and industry solutions [1] - The company's main business revenue composition includes metal cutting machine tools (57.38%), metal forming machine tools (29.20%), and others (13.42%) [1]

Core Viewpoint - China National Pharmaceutical Group's stock has experienced a decline of 2.06% on November 17, with a current price of 11.41 CNY per share and a total market capitalization of 17.068 billion CNY [1] Financial Performance - For the period from January to September 2025, China National Pharmaceutical achieved a revenue of 25.894 billion CNY, a year-on-year decrease of 0.79%, while the net profit attributable to shareholders was 455 million CNY, reflecting a year-on-year increase of 1.70% [2] - The company has cumulatively distributed dividends of 3.795 billion CNY since its A-share listing, with 725 million CNY distributed over the past three years [3] Stock Market Activity - As of 09:54 on November 17, the trading volume was 137 million CNY, with a turnover rate of 0.80% [1] - The stock has seen a year-to-date increase of 3.77%, a decline of 0.78% over the last five trading days, a rise of 3.92% over the last 20 days, and an increase of 5.16% over the last 60 days [1] Shareholder Information - As of September 30, 2025, the number of shareholders was 139,700, an increase of 0.69% from the previous period, with an average of 10,704 circulating shares per shareholder, a decrease of 0.69% [2] - The top ten circulating shareholders include Southern CSI 500 ETF, holding 10.9137 million shares, down by 170,800 shares from the previous period, and Hong Kong Central Clearing Limited, holding 8.3204 million shares, down by 3.7371 million shares [3] Business Overview - China National Pharmaceutical is primarily engaged in the production, processing, and trade of pharmaceuticals, with its main business revenue composition being 75.50% from pharmaceutical commerce, 13.26% from international trade, and 7.69% from pharmaceutical manufacturing [1]

Core Viewpoint - Tonghua Dongbao's stock price has shown fluctuations, with a recent decline of 2.06% and a year-to-date increase of 15.46% [1] Financial Performance - For the period from January to September 2025, Tonghua Dongbao achieved a revenue of 2.18 billion yuan, representing a year-on-year growth of 50.55% [2] - The net profit attributable to shareholders reached 1.20 billion yuan, marking a significant increase of 1911.35% compared to the previous year [2] Stock Market Activity - As of November 17, the stock price was 9.02 yuan per share, with a market capitalization of 17.67 billion yuan [1] - The trading volume showed a net outflow of 8.44 million yuan from main funds, with large orders reflecting a buy of 11.99 million yuan and a sell of 18.38 million yuan [1] Shareholder Information - As of September 30, 2025, the number of shareholders was 82,100, a decrease of 5.08% from the previous period [2] - The average circulating shares per person increased by 5.35% to 23,843 shares [2] Dividend Distribution - Since its A-share listing, Tonghua Dongbao has distributed a total of 5.51 billion yuan in dividends, with 1.48 billion yuan distributed over the last three years [3] Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the third-largest circulating shareholder, increasing its holdings by 15.84 million shares [3] - The Southern CSI 500 ETF reduced its holdings by 352,900 shares, while the Innovation Drug fund increased its holdings by 486,900 shares [3]

这个发现有多硬核？要知道新中国成立76年来，咱们挖过的最大金矿才500吨级，这次直接翻近三倍！更牛的是勘探周期才用了常规时间的一半，质量却杠 杠的。有网友调侃："这哪是挖矿啊，分明是给地球做B超，还精准定位到了'黄金孕囊'！" "辽宁这回直接整了个大活！"当自然资源部2025年11月14日甩出这个重磅消息时，全国网友的DNA都动了——在辽宁地下2500米深处，勘探队居然挖出了 个"黄金巨无霸"！这个名叫大东沟的金矿床，直接把我国黄金储备的"家底"往上抬了好几个台阶。 先甩组数据让大家感受下什么叫"壕无人性"：25.86亿吨金矿石堆起来，能绕地球赤道转三圈半；1444.49吨黄金资源量，相当于把故宫太和殿的金銮宝座熔 了还能再造3000个；最绝的是平均0.56克/吨的品位，虽然听着不高，但架不住人家量大管饱啊！用地质专家的话说："这就像在沙堆里找米粒，结果挖出个 米仓！" 说到这个"黄金孕囊"的发现过程，那真是比侦探破案还刺激。2023年春天，辽宁省地勘局的"找矿天团"在长白山余脉溜达时，发现某处岩石的"脸色"不太对 ——本该灰扑扑的花岗岩，居然泛着若有若无的金属光泽。这帮"岩石侦探"立马掏出放大镜（其实是便携 ...

Core Insights - The stock price of Dajin Heavy Industry increased by 2.19% on November 14, reaching 47.05 CNY per share, with a total market capitalization of 30.006 billion CNY [1] - The company has seen a significant stock price increase of 131.50% year-to-date, with a recent decline of 0.84% over the last five trading days [1] - Dajin Heavy Industry's main business includes the production and sales of wind power tower frames and thermal power boiler steel structures, with wind power equipment accounting for 94.54% of its revenue [1] Financial Performance - For the period from January to September 2025, Dajin Heavy Industry reported a revenue of 4.595 billion CNY, representing a year-on-year growth of 99.25%, and a net profit attributable to shareholders of 888 million CNY, up 214.63% year-on-year [2] - The company has distributed a total of 325 million CNY in dividends since its A-share listing, with 240 million CNY distributed over the past three years [3] Shareholder Structure - As of October 31, 2025, the number of shareholders for Dajin Heavy Industry increased to 67,300, a rise of 15.29%, while the average number of tradable shares per shareholder decreased by 13.26% to 9,381 shares [2] - The second-largest shareholder is Hong Kong Central Clearing Limited, holding 22.0823 million shares, an increase of 2.6702 million shares from the previous period [3] - New institutional shareholders include Southern CSI 1000 ETF and Dongfanghong Qiyuan Three-Year Holding Mixed A, which have entered the top ten circulating shareholders list [3]

Core Viewpoint - The stock of FAW Jiefang has shown a slight increase recently, with a year-to-date decline, indicating potential volatility in the market [1][2]. Group 1: Stock Performance - As of November 14, FAW Jiefang's stock price increased by 2.03% to 7.54 CNY per share, with a trading volume of 54.30 million CNY and a turnover rate of 0.15%, resulting in a total market capitalization of 37.11 billion CNY [1]. - Year-to-date, FAW Jiefang's stock has decreased by 7.48%, but it has seen a 3.01% increase over the last five trading days, an 8.18% increase over the last 20 days, and an 8.02% increase over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, FAW Jiefang reported a revenue of 43.996 billion CNY, a year-on-year decrease of 2.52%, while the net profit attributable to shareholders was 372 million CNY, reflecting a year-on-year increase of 2.34% [2]. - The company has distributed a total of 10.055 billion CNY in dividends since its A-share listing, with 940 million CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for FAW Jiefang reached 82,000, an increase of 4.65% from the previous period, while the average number of circulating shares per person decreased by 4.44% to 60,035 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 35.54 million shares, a decrease of 2.57 million shares from the previous period, while E Fund CSI 300 ETF is a new entrant with 12.11 million shares [3].